TG Therapeutics reported $594M in 2025 U.S. BRIUMVI sales, a 90% YoY increase, and guides for $825–$850M in 2026. Click here ...
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...
ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, ...
Researchers at the Sanford Stem Cell Institute have taken the fight against rare diseases to the lab, to patients’ bedsides ...
Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients' ...
Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and ...
CARSON CITY, Nev., Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
Cut off from established pathways for managing a chronic illness, many Vermonters with long Covid have reported living in a sort of permanent limbo. They have faced stigma and disbelief from loved ...
Sarepta Therapeutics, Inc. ( SRPT) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST ...
A recent clinical trial has explored a new approach using a psychedelic drug called dimethyltryptamine, or DMT. Psychedelic drugs affect perception, mood, and thinking, and some have shown potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results